UNUSUAL ADVERSE DRUG REACTIONS IN HIGH GRADE GLIOMA PATIENTS TREATED WITH TEMOZOLOMIDE

被引：0
|
作者：
Lisa, Boris [1 ]
Vera, Elizabeth [2 ]
Wu, Jing [3 ]
Park, Deric M. [4 ]
Bryla, Christine [3 ]
Crandon, Sonja [5 ]
Garren, Nancy [1 ]
Mccoy, Ann [3 ]
Siegel, Christine [5 ]
Theeler, Brett J. [6 ]
Sul, Joo-Hee [7 ]
Gilbert, Mark [3 ]
Armstrong, Terri [5 ]
机构：
[1] NCI, NIH, Bethesda, MD 20892 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA
[4] NCI, Neurooncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[5] NIH, Neurooncol Branch, Bldg 10, Bethesda, MD 20892 USA
[6] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA
[7] US FDA, Silver Spring, MD USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
QLIF-03
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [31] Retrospective evaluation of newly diagnosed high grade glioma patients treated by radiotherapy, concomitant and/or adjuvant temozolomide: A single center study.
    Akmansu, M.
    Goksel, F.
    Bora, H.
    Unsal, D.
    Buyukberber, S.
    Yaman, E.
    Karahacioglu, E.
    Yamac, D.
    Pak, Y.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S298 - S298
  • [32] Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status
    J Janinis
    E Efstathiou
    C Panopoulos
    E Samantas
    G Aravantinos
    Ch Christodoulou
    D Skarlos
    Medical Oncology, 2000, 17 : 106 - 110
  • [33] Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy
    Zhou, Xiaofeng
    Liao, Xiaofang
    Zhang, Bicheng
    He, Huijuan
    Shui, Yongjie
    Xu, Wenhong
    Jiang, Chaogen
    Shen, Li
    Wei, Qichun
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (02) : 289 - 294
  • [34] Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma
    Abacioglu, Ufuk
    Caglar, Hale B.
    Yumuk, Perran F.
    Akgun, Zuleyha
    Atasoy, Beste M.
    Sengoz, Meric
    JOURNAL OF NEURO-ONCOLOGY, 2011, 103 (03) : 585 - 593
  • [35] Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma
    Ufuk Abacioglu
    Hale B. Caglar
    Perran F. Yumuk
    Zuleyha Akgun
    Beste M. Atasoy
    Meric Sengoz
    Journal of Neuro-Oncology, 2011, 103 : 585 - 593
  • [36] Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma
    Hau, P.
    Koch, D.
    Hundsberger, T.
    Marg, E.
    Bauer, B.
    Rudolph, R.
    Rauch, M.
    Brenner, A.
    Rieckmann, P.
    Schuth, J.
    Jauch, T.
    Koch, H.
    Bogdahn, U.
    NEUROLOGY, 2007, 68 (09) : 688 - 690
  • [37] Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status
    Janinis, J
    Efstathiou, E
    Panopoulos, C
    Samantas, E
    Aravantinos, G
    Christodoulou, C
    Skarlos, D
    MEDICAL ONCOLOGY, 2000, 17 (02) : 106 - 110
  • [38] Adverse drug reactions in patients treated for colorectal cancer: from the oncologists to the patients
    Deligne, D.
    Noize, P.
    Haramburu, F.
    Grelaud, A.
    Rouyer, M.
    Smith, D.
    Fourrier-Reglat, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 40 - 40
  • [39] HEMATOLOGICAL ADVERSE EVENTS IN GLIOBLASTOMA PATIENTS TREATED WITH TEMOZOLOMIDE
    Garcia, Catherine
    Myint, Zin
    Jayswal, Rani
    Butts, Allison
    Weiss, Heidi
    Villano, John
    NEURO-ONCOLOGY, 2019, 21 : 75 - 76
  • [40] Temozolomide in paediatric high-grade glioma: a key for combination therapy?
    A C Verschuur
    J Grill
    A Lelouch-Tubiana
    D Couanet
    C Kalifa
    G Vassal
    British Journal of Cancer, 2004, 91 : 425 - 429
12345